Engineered Attachment Sites Raise Bxb1 Integration

Institution: Qi Biodesign · Method: Engineered attB Attachment Sites (Bxb1 Integrase) · Cargo Demonstrated: CD19-CAR (31%) + OTC Cassette (25%) · Study Type: Peer-Reviewed (Nature Biotechnology) · Date: September 2, 2026 Summary Qi Biodesign researchers rationally engineered Bxb1 attachment-site DNA rather than only the integrase…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *